What is the treatment for Group B Streptococcus (GBS) urinary tract infection (UTI)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Group B Streptococcus (GBS) urinary tract infections should be treated with antibiotics, with the choice of antibiotic and duration of treatment depending on the severity of the infection and the patient's allergy status, as recommended by the most recent guidelines 1. For uncomplicated GBS UTIs, the treatment options include amoxicillin 500 mg three times daily for 5-7 days, or alternatives such as cephalexin 500 mg four times daily for 5-7 days or clindamycin 300 mg four times daily for 5-7 days for penicillin-allergic patients. Some key points to consider when treating GBS UTIs include:

  • Completing the full course of antibiotics even if symptoms improve before finishing treatment
  • Drinking plenty of water to help flush bacteria from the urinary system
  • Being aware of the potential for serious complications if left untreated, especially in pregnant women, newborns, elderly individuals, or those with compromised immune systems
  • Considering the use of short-course antibiotics, such as nitrofurantoin for 5 days, trimethoprim-sulfamethoxazole for 3 days, or fosfomycin as a single dose, for uncomplicated cystitis, as recommended by the American College of Physicians 1. It's also important to note that the treatment of GBS UTIs should be guided by the most recent and highest quality evidence, and that the choice of antibiotic and duration of treatment should be individualized based on the patient's specific needs and circumstances, as recommended by the guidelines 1.

From the FDA Drug Label

Clinical Indication Dosage Serious infections, such as pneumonia and endocarditis, due to susceptible strains of streptococci (including S pneumoniae) and meningococcus 150,000 - 300,000 units/kg/day divided in equal doses every 4 to 6 hours; duration depends on infecting organ-ism and type of infection

The treatment for strep B UTI infection is not explicitly mentioned in the provided drug label. However, based on the available information for serious infections due to susceptible strains of streptococci, the dosage of penicillin G (IV) is 150,000 - 300,000 units/kg/day divided in equal doses every 4 to 6 hours. The duration of treatment depends on the infecting organism and type of infection 2.

  • Key points:
    • Dosage: 150,000 - 300,000 units/kg/day
    • Administration: divided in equal doses every 4 to 6 hours
    • Duration: depends on the infecting organism and type of infection
    • Note: The provided drug label does not explicitly address strep B UTI infection treatment.

From the Research

Strep B UTI Infection Treatment

  • The treatment of Strep B UTI infection typically involves the use of antibiotics, with penicillin being a commonly used option 3.
  • However, there have been reports of reduced susceptibility to beta-lactam antibiotics, including penicillin, in some countries 3.
  • In cases where patients are allergic to penicillin, second-line antibiotics such as erythromycin and clindamycin may be used, although resistance to these antibiotics is common 4, 5.
  • Vancomycin is often used as a last resort antibiotic, although there have been cases of vancomycin resistance in GBS 3.

Antibiotic Resistance

  • GBS has been shown to exhibit high levels of multidrug resistance, with a high proportion of isolates resistant to erythromycin, clindamycin, and tetracycline 4.
  • The use of erythromycin has been shown to have a protective effect against oxidative stress in GBS, although the clinical significance of this is unclear 4.
  • Resistance to fluoroquinolones and aminoglycosides has also been reported, highlighting the need for careful antibiotic selection and monitoring 3.

Clinical Characteristics

  • GBS UTI infection can occur in both pregnant and non-pregnant adults, with underlying medical conditions and urinary tract abnormalities increasing the risk of infection 6.
  • The clinical manifestations of GBS UTI infection can vary, with symptoms ranging from cystitis to pyelonephritis 5, 6.
  • The treatment of GBS UTI infection typically involves the use of antibiotics, with the goal of reducing symptoms and preventing complications 7.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.